Page 24 - Maximizing the efficacy of ankle foot orthoses in children with cerebral palsy
P. 24

24
Chapter I
referenceS
[1] Cans C, Guillem P, Arnoud C, Baille F, Chalmers J, McManus V, Cussen G, Parkes J,
Dolk H, Hagberg G, Jarvis S, Colver A, Johnson A, Surman G, Krageloh-Mann I, Michaelis R, Platt MJ, Pharoah P, Topp M, Udall P, Torrioli MG, Miceli M. Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol 2002, 44(9); 633-40.
[2] Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil. Rehabil. 2006, 28(4); 183-91.
[3] Himmelmann K, Uvebrant P. The panorama of cerebral palsy in Sweden. XI. Changing patterns in the birth-year period 2003-2006. Acta Paediatr. 2014, 103(6); 618-24.
[4] Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, Jacobsson B, Damiano D. Proposed definition and classification of cerebral palsy, April 2005. Dev. Med. Child Neurol. 2005, 47(8); 571-6.
[5] Becher JG, Gorter JW, Vermeulen J, van Schie P, Wiegerink D. Cerebrale Parese, In: Kinderrevalidatie, 2015, pp. 351-94.
[6] Himmelmann K, Uvebrant P. The panorama of cerebral palsy in Sweden. XI. Changing patterns in the birth-year period 2003-2006. Acta Paediatr. 2014, 103(6); 618-24.
[7] Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B. A report: the definition and classification of cerebral palsy April 2006. Dev. Med. Child Neurol. Suppl 2007, 109; 8-14.
[8] Dietz V, Sinkjaer T. Spastic movement disorder: impaired reflex function and altered muscle mechanics. Lancet Neurol 2007, 6(8); 725-33.
[9] Lance JW. Pathophysiology of spasticity and clinical experience with baclofen, In: Spasticity: disordered motor control, Chicago, Year Book Medical Publishers, 1980, pp. 185-203.
[10] Fry NR, Gough M, Shortland AP. Three- dimensional realisation of muscle morphology and architecture using ultrasound. Gait. Posture. 2004, 20(2); 177-82.
[11] Hof AL. Changes in muscles and tendons due to neural motor disorders: implications for therapeutic intervention. Neural Plast. 2001, 8(1-2); 71-81.
[12] Graham HK, Selber P. Musculoskeletal aspects of cerebral palsy. J. Bone Joint Surg. Br. 2003, 85-B(2); 157-66.
[13] Cans C. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev. Med. Child Neurol. 2000, 42(12); 816-24.
[14] Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function
in children with cerebral palsy. Dev. Med. Child Neurol. 1997, 39(4); 214-23.
[15] Perry J, Schoneberger B. Gait analysis : normal and pathological function, Thorofare, NJ, SLACK Incorporated, 1992.
[16] Gage JR, DeLuca PA, Renshaw TS. Gait analysis: principle and applications with emphasis on its use in cerebral palsy. Instr. Course Lect. 1996, 45; 491-507.
[17] Waters RL, Mulroy S. The energy expenditure of normal and pathologic gait. Gait. Posture. 1999, 9(3); 207-31.
[18] Van de Walle P, Desloovere K, Truijen S, Gosselink R, Aerts P, Hallemans A. Age-related changes in mechanical and metabolic energy during typical gait. Gait. Posture. 2010, 31(4); 495- 501.
[19] Dobson F, Morris ME, Baker R, Graham HK. Gait classification in children with cerebral palsy: a systematic review. Gait. Posture. 2007, 25(1); 140-52.
[20] Becher JG. Pediatric rehabilitation
in children with Cerebral Palsy: General management, classification of motor disorders. J. Prosthet. Orthot. 2002, 14(4); 143-9.
[21] Crenna P. Spasticity and ‘spastic’ gait in children with cerebral palsy. Neurosci. Biobehav. Rev. 1998, 22(4); 571-8.


































































































   22   23   24   25   26